Literature DB >> 17701476

Sirtuins: the 'magnificent seven', function, metabolism and longevity.

Nassim Dali-Youcef1, Marie Lagouge, Sébastien Froelich, Christian Koehl, Kristina Schoonjans, Johan Auwerx.   

Abstract

The sirtuin family of histone deacetylases (HDACs) was named after their homology to the Saccharomyces cerevisiae gene silent information regulator 2 (Sir2). In the yeast, Sir2 has been shown to mediate the effects of calorie restriction on the extension of life span and high levels of Sir2 activity promote longevity. Like their yeast homologs, the mammalian sirtuins (SIRT1-7) are class III HDACs and require NAD(+) as a cofactor to deacetylate substrates ranging from histones to transcriptional regulators. Through this activity, sirtuins are shown to regulate important biological processes ranging from apoptosis, adipocyte and muscle differentiation, and energy expenditure to gluconeogenesis. We review here the current knowledge regarding the role of sirtuins in metabolism, longevity, and discuss the possible therapeutic applications that could result from the understanding of their function in different organs and pathologies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701476     DOI: 10.1080/07853890701408194

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  171 in total

Review 1.  Protective effects and mechanisms of sirtuins in the nervous system.

Authors:  Feng Zhang; Suping Wang; Li Gan; Peter S Vosler; Yanqin Gao; Michael J Zigmond; Jun Chen
Journal:  Prog Neurobiol       Date:  2011-09-10       Impact factor: 11.685

Review 2.  Sirtuins in neurodegenerative diseases: a biological-chemical perspective.

Authors:  Aparna Raghavan; Zahoor A Shah
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

Review 3.  Oxidative stress and NAD+ in ischemic brain injury: current advances and future perspectives.

Authors:  W Ying; Z-G Xiong
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

4.  Isoform-specific targeting and interaction domains in human nicotinamide mononucleotide adenylyltransferases.

Authors:  Corinna Lau; Christian Dölle; Toni I Gossmann; Line Agledal; Marc Niere; Mathias Ziegler
Journal:  J Biol Chem       Date:  2010-04-13       Impact factor: 5.157

Review 5.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

6.  Calorie restriction for optimal cardiovascular aging: the weight of evidence.

Authors:  Emanuele Marzetti; Stephanie E Wohlgemuth; Angelo G Aulisa; Roberto Bernabei; Marco Pahor; Christiaan Leeuwenburgh
Journal:  Curr Cardiovasc Risk Rep       Date:  2010-09-01

7.  A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease.

Authors:  Marianne R Smith; Adeela Syed; Tamas Lukacsovich; Judy Purcell; Brett A Barbaro; Shane A Worthge; Stephen R Wei; Giuseppe Pollio; Letizia Magnoni; Carla Scali; Luisa Massai; Davide Franceschini; Michela Camarri; Marco Gianfriddo; Enrica Diodato; Russell Thomas; Ozgun Gokce; S J Tabrizi; Andrea Caricasole; Bernard Landwehrmeyer; Liliana Menalled; Carol Murphy; Sylvie Ramboz; Ruth Luthi-Carter; Goran Westerberg; J Lawrence Marsh
Journal:  Hum Mol Genet       Date:  2014-01-16       Impact factor: 6.150

Review 8.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

Review 9.  Epigenetics and the control of epithelial sodium channel expression in collecting duct.

Authors:  Dongyu Zhang; Zhi-yuan Yu; Pedro Cruz; Qun Kong; Shiyu Li; Bruce C Kone
Journal:  Kidney Int       Date:  2008-09-24       Impact factor: 10.612

Review 10.  A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis.

Authors:  Shin-Ichiro Imai
Journal:  Pharmacol Res       Date:  2010-01-18       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.